Allosteric effects of DNA on transcriptional regulators

Nature

Volumn 392, Issue 6679, 1998, Pages 885-888

  Lefstin, Jeffrey A ^a   Yamamoto, Keith R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; REGULATOR PROTEIN;

GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA INTERACTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ALLOSTERIC REGULATION; DIMERIZATION; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; PROTEIN CONFORMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REGULATORY SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032580207     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/31860     Document Type: Review

References (66)

1. Ptashne, M. How eukaryotic transcriptional activators work. Nature 335, 683-689 (1988).
2. Nguyen, J. T. & Lim, W. A. How Src exercises self-restraint. Nature Struct. Biol. 4, 256-260 (1997).
3. Luo, X. & Sawadogo, M. Functional domains of the transcription factor USD2: atypical nuclear localization signals and context-dependent transcriptional activation domains, Mol. Cell. Biol. 16, 1367-1375 (1996).
4. Johansen, F. E. & Prywes, R. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol. Cell. Biol. 13, 4640-4647 (1993).
5. Li, X. Y. & Green, M. R. Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 10, 517-527 (1996).
6. Brehm, A., Ohbo, K. & Schöler, H. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 17, 154-162 (1997).
7. Petersen, J. M. et al. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. Science 269, 1866-1869 (1995).
8. Meierhans, D. et al. DNA binding specificity of the basic-helix-loop-helix protein MASH-1. Biochemistry 34, 11026-11036 (1995).
9. Weiss, M. A. et al. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature 347, 575-578 (1990).
10. Shuman, J. D., Vinson, C. R. & McKnight, S. L. Evidence of changes in protease sensitivity and subunit exchange rate on DNA binding by C/EBP. Science 249, 771-774 (1990).
11. Patel, L., Abate, C. & Curran, T. Altered protein conformation on DNA binding by Fos and Jun. Nature 347, 572-575 (1990).
12. Epstein, J. et al. Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J. Biol. Chem. 269, 8355-8361 (1994).
13. Ikeda, M. et al. Different DNA elements can modulate the conformation of thyroid hormone receptor heterodimer and its transcriptional activity. J. Biol. Chem. 271, 23096-23104 (1996).
14. Tan, S. & Richmond, T. J, DNA binding-induced conformational change of the yeast transcriptional activator PRTF. Cell 62, 367-377 (1990).
15. Cleary, M. A., Pendergrast, S. & Herr, W. Structural flexibility in transcription complex formation revealed by protein-DNA photocrosslinking. Proc. Natl Acad. Sci. USA 94, 8450-8455 (1997).
16. Donaldson, L. W., Petersen, J. M., Graves, B. J. & McInrosh, L. P. Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif. EMBO J. 15, 125-134 (1996).
17. Werner, M. H. et al. The solution structure of the human ETS1-DNA complex reveals a noval mode of binding and true side chain intercalation. Cell 38, 761-771 (1995).
18. Jonsen, M. D., Petersen, J. M., Xu, Q. P. & Graves, B. J. Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol. Cell. Biol. 16, 2065-2073 (1996).
19. Skalicky, J. J., Donaldson, L. W., Petersen, J. M., Graves, B. J. & McIntosh, L. P. Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1. Protein Sci. 5, 296-309 (1996).
20. Miner, J. N. & Yamamoto, K. R. Regulatory crosstalk at composite response elements. Trends Biochem. Sci. 16, 426-426 (1991).
21. Wagner, S. & Green, M. R. DNA-binding domains: targets for viral and cellular regulatory. Curr. Opin. Cell Biol. 6, 410-441 (1994).
22. Martin, M. L., Lieberman, P. M. & Curran, T. Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF. Mol. Cell. Biol. 16, 2110-2118 (1996).
23. Eckner, R., Yao, T., Oldread, E. & Livingston, D. M. Interaction and functional collaboration of p300/ CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10, 2478-2490 (1996).
24. Sartorelli, V. et al. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17, 1010-1026 (1997).
25. Huasg, C. C. & Herr, W. Differential control of transcription by homologous homeodomain coregulators. Mol. Cell. Biol. 16, 2967-2976 (1996).
26. Misra, V. et al. Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators. Mol. Cell. Biol. 16, 4404-4413 (1996).
27. Walker, S., Hayes, S. & O'Hare, P. Site-specific conformational alteration of the Oct-1 POU domainDNA complex as the basis for differential recognition by Vmw65 (VP16). Cell 79, 841-852 (1994).
28. Johansen, F. E. & Prywes, R. Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol. Cell. Biol. 14, 5920-5928 (1994).
29. Hill, C. S., Wynne, J. & Treisman, R. Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J. 13, 5421-5432 (1994).
30. Chen, J. D. & Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457 (1995).
31. Mangelsdorf, D. J. et al. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66, 555-561 (1991).
32. Kurokawa, R. et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377, 451-454 (1995).
33. Kurokawa, R. et al. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371, 528-531 (1994).
34. Saatcioglu, F., Deng, T. & Karin, M. A novel as element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation. Cell 75, 1095-1105 (1993).
35. Rahman, A., Esmaili, A. & Saatcioglu, F. A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp 1 binding sites. J. Biol. Chem. 207, 31059-31064 (1995).
36. Tomie-Canie, M., Day, D., Samuela, H. H., Freedberg, I. M. & Blumenberg, M. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptors. J. Biol. Chem. 271, 1416-1423 (1996).
37. Härd, T. et al Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249, 157-160 (1990).
38. Luisi, B. F. et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505 (1991).
39. Baumann, H. et al. Refined solution structure of the glucocorticoid receptor DNA-binding domain. Biochemistry 32, 13463-13471 (1993).
40. van Tilborg, M. A. et al. Structure refinement of the glucocorticoid receptor-DNA binding domain from NMR data by relaxation matrix calculations. J. Mol. Biol. 247, 689-700 (1995).
41. Schwabe, J. W. R. et al. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75, 567-578 (1993).
42. Schwabe, J. W. et al. The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. Structure 3, 201-213 (1995).
43. Dahlman-Wright, K. et al. Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J. Biol. Chem. 266, 3107-3112 (1991).
44. Drouin, J. et al. Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor. Mol. Endocrinol. 6, 1299-1309 (1992).
45. Yamamoto, K. R., Pearce, D., Thomas, J. & Miner, J. N. in Transcriptional Regulation (eds McKnight, S. L. & Yamamoto, K. R.) 1169-1170 (Cold Spring Harbor Laboratory Press, NY, 1992).
46. Heck, S. et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13, 4087-4095 (1994).
47. Lefstin, J. A., Thomas, J. R. & Yamamoto, K. R. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 8, 2842-2856 (1994).
48. Cato, A. C. & Wade, E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioassays 18, 371-378 (1996).
49. Drouin, J. et al. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12, 145-156 (1993).
50. König, H., Ponta, H., Rahmsdorf, H. J. & Herrlich, P. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11, 2241-2246 (1992).
51. Diamond, M. I. et al. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249, 1266-1271 (1990).
52. Jonat, C. et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62, 1189-1204 (1990).
53. Yang-yen, H.-F. et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205-1215 (1990).
54. Starr, D. B. et al. Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Dev. 10, 1271-1283 (1996).
55. Saudek, V. et al. Solution structure of the basic region from the transcriptional activator GCN4. Biochemistry 30, 1310-1317 (1991).
56. Ellenberger, T. E. et al. The GCN4 basic leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell 71, 1223-1237 (1992).
57. O'Neil, K. T., Shuman, J. D., Ampe, C. & DeGrado, W. F. DNA-induced increase in the alpha-helical content of C/EBP and GCN4. Biochemistry 30, 9030-9034 (1991).
58. Krebs, D. et al. The basic subdomain of the c-Jun oncoprotein. A joint CD, Fourier-transform infrared and NMR study. Eur. J. Biochem. 231, 370-380 (1995).
59. Ebneth, A. et al. Biophysical characterization of the c-Myb DNA-binding domain. Biochemistry 33, 14586-14593 (1994).
60. Ogata, K. et al. The cavity in the hydrophobic core of Myb DNA-binding domain is reserved for DNA recognition and trans-activation. Nature Struct. Biol. 3, 178-187 (1996).
61. Jamin, N. et al. Secondary structure of the DNA-binding domain of the c-Myb oncoprotein in solution. A multidimensional double and triple heteronuclear NMR study. Eut. J. Biochem. 216, 147-154 (1993).
62. Carr, M. D. et al. Structure of the B-Myb DNA-binding domain in solution and evidence for multiple conformations in the region of repeat-2 involved in DNA binding: implications for sequence-specific DNA binding by Myb proteins. Eur. J. Biochem. 235, 721-735 (1996).
63. Fujita, T., Nolan, G. P., Ghosh, S. & Baltimore, D. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 6, 775-787 (1992).
64. Hay, R. T. & Nicholson, J. DNA binding alters the protease susceptibility of the p50 subunit of NF-KappaB. Nucleic Acids Res. 21, 4592-4598 (1993).
65. Matthews, J. R. et al. Conformational changes induced by DNA binding of NF-kappa B. Nucleic Acids Res. 23, 3393-3402 (1995).
66. Toney, J. H. et al. Conformational changes in chicken thyroid hormone receptor alpha 1 induced by binding to ligand or to DNA. Biochemistry 32, 2-6 (1993).